{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:44:40Z","timestamp":1787319880652,"version":"build-2736575974"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01483","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T01:39:46Z","timestamp":1594863586000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Editorial: ADAM10 in Cancer Immunology and Autoimmunity: More Than a Simple Biochemical Scissor"],"prefix":"10.3389","volume":"11","author":[{"given":"Armando","family":"Rossello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Steinle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Poggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Zocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.semcdb.2008.11.002","article-title":"The \u201cA Disintegrin And Metalloprotease\u201d (ADAM) family of sheddases: physiological and cellular functions","volume":"20","author":"Reiss","year":"2009","journal-title":"Semin Cell Dev Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2015.10.003","article-title":"The alpha secretase ADAM10: a metalloprotease with multiple functions in the brain","volume":"135","author":"Saftig","year":"2015","journal-title":"Prog Neurobiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1158\/1078-0432.CCR-08-1585","article-title":"Role of ADAMs in cancer formation and progression","volume":"15","author":"Duffy","year":"2009","journal-title":"Clin Cancer Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/nrc2459","article-title":"The ADAMs: signalling scissors in the tumor microenvironment","volume":"8","author":"Murphy","year":"2008","journal-title":"Nat Rev Cancer."},{"key":"B5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41577-018-0068-5","article-title":"The emerging role of ADAM metalloproteinases in immunity","volume":"18","author":"Lambrecht","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.molimm.2010.12.005","article-title":"The emergence of ADAM10 as a regulator of lymphocyte development and autoimmunity","volume":"48","author":"Gibb","year":"2011","journal-title":"Mol Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/09537104.2016.1203396","article-title":"Considerations on inhibition approaches for proinflammatory functions of ADAM proteases","volume":"28","author":"Dreymueller","year":"2017","journal-title":"Platelets."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1158\/0008-5472.CAN-07-6768","article-title":"Tumor-associated MICA is shed by ADAM proteases","volume":"68","author":"Waldhauer","year":"2008","journal-title":"Cancer Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/nature01112","article-title":"Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation","volume":"419","author":"Groh","year":"2002","journal-title":"Nature."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.4049\/jimmunol.169.8.4098","article-title":"Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding","volume":"169","author":"Salih","year":"2002","journal-title":"J Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1182\/blood-2003-01-0019","article-title":"Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia","volume":"102","author":"Salih","year":"2003","journal-title":"Blood."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1182\/blood-2011-07-370841","article-title":"High ERp5\/ADAM10 expression in lymph node microenvironment and impaired NKG2D-ligands recognition in Hodgkin lymphomas","volume":"119","author":"Zocchi","year":"2012","journal-title":"Blood."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/ijc.28174","article-title":"Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the \u201ca disintegrin and metalloproteases\u201d 10 and 17","volume":"133","author":"Chitadze","year":"2013","journal-title":"Int J Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1158\/0008-5472.CAN-06-2470","article-title":"ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro","volume":"67","author":"Eichenauer","year":"2007","journal-title":"Cancer Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1042\/BST20160290","article-title":"Scissor sisters: regulation of ADAM10 by the TspanC8 tetraspanins","volume":"45","author":"Matthews","year":"2017","journal-title":"Biochem Soc Trans."},{"key":"B16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1559-0275-8-9","article-title":"The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?","volume":"8","author":"Duffy","year":"2011","journal-title":"Clin Proteomics."},{"key":"B17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ejcb.2010.11.005","article-title":"The \u201cA Disintegrin And Metalloproteases\u201d ADAM10 and ADAM17: novel drug targets with therapeutic potential?","volume":"90","author":"Saftig","year":"2011","journal-title":"Eur J Cell Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.bbamcr.2017.06.005","article-title":"The metalloproteinase ADAM10: a useful therapeutic target?","volume":"1864","author":"Wetzel","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e27089","DOI":"10.4161\/onci.27089","article-title":"How to exploit stress-related immunity against Hodgkin's lymphoma: targeting ERp5 and ADAM sheddases","volume":"2","author":"Poggi","year":"2013","journal-title":"Oncoimmunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1123367","DOI":"10.1080\/2162402X.2015.1123367","article-title":"(2016) ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing","volume":"5","author":"Zocchi","year":"2015","journal-title":"Oncoimmunology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ejmech.2016.01.053","article-title":"Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models","volume":"111","author":"Camodeca","year":"2016","journal-title":"Eur J Med Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.21873\/anticanres.11981","article-title":"Effects of ADAM10 and ADAM17 inhibitors on natural killer cell expansion and antibody-dependent cellular cytotoxicity against breast cancer cells","volume":"37","author":"Pham","year":"2017","journal-title":"In Vitro. Anticancer Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nature24014","article-title":"Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma","volume":"549","author":"Venkatesh","year":"2017","journal-title":"Nature."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1421889","DOI":"10.1080\/2162402X.2017.1421889","article-title":"Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells","volume":"7","author":"Tosetti","year":"2018","journal-title":"Oncoimmunology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"30523","DOI":"10.18632\/oncotarget.8864","article-title":"CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro","volume":"7","author":"Hansen","year":"2016","journal-title":"Oncotarget."},{"key":"B26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00262-019-02437-2","article-title":"Proteolytic processing of PD-L1 by ADAM proteases in breast cancer cells","volume":"69","author":"Romero","year":"2020","journal-title":"Cancer Immunol Immunother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1744980","DOI":"10.1080\/2162402X.2020.1744980","article-title":"ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance","volume":"9","author":"Orme","year":"2020","journal-title":"Oncoimmunology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41598-016-0013-4","article-title":"Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate","volume":"6","author":"Madoux","year":"2016","journal-title":"Sci Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.canlet.2019.10.003","article-title":"ADAM proteases: emerging role and targeting of the non-catalytic domains","volume":"467","author":"Saha","year":"2019","journal-title":"Cancer Lett."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01483\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T01:39:49Z","timestamp":1594863589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01483\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2020.01483"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01483","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"article-number":"1483"}}